Breaking Down Biotech's Bloodbath: Which Companies To Buy
Industry Focus
The Motley Fool
4.6 • 854 Ratings
🗓️ 7 October 2015
⏱️ 18 minutes
🧾️ Download transcript
Summary
Biotech stocks may have fallen sharply in the past few months, but that doesn't mean that everyone of them should be avoided. In this episode, we uncork some of our best ideas for investors to buy.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Unpacking the big opportunity in Biotech's bloodbath. This is industry focus. |
| 0:07.0 | Hi Fool's health care analyst Michael Douglas here today. For those of you who are expecting to hear Christine, I am sorry. She is on vacation and I am filling in so get ready for some vocalized pauses. But I am joined by Todd Campbell, |
| 0:24.2 | our regular contributor here in industry focus. |
| 0:26.2 | Todd, great to have you. |
| 0:27.9 | Oh, I'm happy to be here. |
| 0:29.0 | It's good to see back in the seat at least for this week. |
| 0:32.4 | You're very kind. |
| 0:34.0 | Hopefully not our only on-core performance of the original industry focus health care team, |
| 0:39.0 | but we'll see how that goes. |
| 0:42.0 | So today I wanted to talk a little bit about |
| 0:43.6 | well biotechs just had a rough couple of months the I. B. B. is down what is it Todd |
| 0:51.2 | 20%? |
| 0:52.8 | 21% just since July. |
| 0:55.0 | Yeah, that's one of your major biotech indices. |
| 0:59.2 | Just, those of us who follow health care very closely and invest accordingly heavily, |
| 1:06.0 | our portfolios are suffering. |
| 1:08.0 | Certainly mine is, I don't know about yours, Todd. |
| 1:11.0 | Well, I'm taking it on the chin as well, you know, the long-term thesis that we're going to stay with it, right? |
| 1:16.8 | Right, exactly. |
| 1:17.8 | And I think that's one of the big things. |
| 1:21.6 | In today's episode, we're going to talk a little bit about why biotech's been down. |
| 1:25.0 | Then we'll segue into, okay, well, so what's a long-term investor to do? |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

